SI1761515T1 - 2-(hetero-)aril substituirani derivati tetrahidrokinolina - Google Patents
2-(hetero-)aril substituirani derivati tetrahidrokinolinaInfo
- Publication number
- SI1761515T1 SI1761515T1 SI200430985T SI200430985T SI1761515T1 SI 1761515 T1 SI1761515 T1 SI 1761515T1 SI 200430985 T SI200430985 T SI 200430985T SI 200430985 T SI200430985 T SI 200430985T SI 1761515 T1 SI1761515 T1 SI 1761515T1
- Authority
- SI
- Slovenia
- Prior art keywords
- nnr
- nar
- halo
- aryl
- coor
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/4706—4-Aminoquinolines; 8-Aminoquinolines, e.g. chloroquine, primaquine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/4709—Non-condensed quinolines and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/4738—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems
- A61K31/4745—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems condensed with ring systems having nitrogen as a ring hetero atom, e.g. phenantrolines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/04—Ortho-condensed systems
- C07D491/044—Ortho-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring
- C07D491/052—Ortho-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring the oxygen-containing ring being six-membered
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/12—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains three hetero rings
- C07D491/14—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oncology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Hematology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Plural Heterocyclic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Saccharide Compounds (AREA)
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE10360154A DE10360154A1 (de) | 2003-12-20 | 2003-12-20 | Tetrahydrochinoline |
| US53996104P | 2004-01-30 | 2004-01-30 | |
| DE102004026026A DE102004026026A1 (de) | 2004-05-27 | 2004-05-27 | Tetrahydrochinoline |
| EP04803833A EP1761515B1 (de) | 2003-12-20 | 2004-12-14 | 2-(hetero-)aryl substituierte tetrahydrochinolinderivate |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SI1761515T1 true SI1761515T1 (sl) | 2009-02-28 |
Family
ID=43969203
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SI200430985T SI1761515T1 (sl) | 2003-12-20 | 2004-12-14 | 2-(hetero-)aril substituirani derivati tetrahidrokinolina |
| SI200431714T SI2033959T1 (sl) | 2003-12-20 | 2004-12-14 | Derivati tetrahidropiranokinolina |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SI200431714T SI2033959T1 (sl) | 2003-12-20 | 2004-12-14 | Derivati tetrahidropiranokinolina |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US7868172B2 (sl) |
| EP (2) | EP2033959B1 (sl) |
| JP (1) | JP5237555B2 (sl) |
| AT (2) | ATE413393T1 (sl) |
| AU (1) | AU2004309028B9 (sl) |
| BR (1) | BRPI0417838A (sl) |
| CA (1) | CA2550350C (sl) |
| DE (1) | DE502004012458D1 (sl) |
| DK (2) | DK2033959T3 (sl) |
| ES (1) | ES2315727T3 (sl) |
| PL (2) | PL2033959T3 (sl) |
| PT (2) | PT2033959E (sl) |
| SI (2) | SI1761515T1 (sl) |
| WO (1) | WO2005063735A1 (sl) |
Families Citing this family (24)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0219660D0 (en) | 2002-08-23 | 2002-10-02 | Astrazeneca Ab | Therapeutic use |
| GB0403744D0 (en) | 2004-02-20 | 2004-03-24 | Astrazeneca Ab | Chemical process |
| GB0425854D0 (en) * | 2004-11-25 | 2004-12-29 | Astrazeneca Ab | Therapeutic treatment |
| DE102005027170A1 (de) * | 2005-06-13 | 2006-12-14 | Merck Patent Gmbh | Substituierte Tetrahydrochinoline |
| US7875721B2 (en) | 2005-08-04 | 2011-01-25 | Stc.Unm | Compounds for binding to ERα/β and GPR30, methods of treating disease states and conditions mediated through these receptors and identification thereof |
| MX2008016071A (es) * | 2006-06-19 | 2009-01-15 | Merck Patent Gmbh | Formas polimorficas y proceso. |
| DE102007013854A1 (de) * | 2007-03-20 | 2008-09-25 | Merck Patent Gmbh | Tetrahydrochinoline |
| DE102007013856A1 (de) | 2007-03-20 | 2008-09-25 | Merck Patent Gmbh | Substituierte Tetrahydropyrrolochinoline |
| DE102007013855A1 (de) * | 2007-03-20 | 2008-09-25 | Merck Patent Gmbh | Substituierte Tetrahydrochinoline |
| DE102007021862A1 (de) * | 2007-05-10 | 2008-11-13 | Merck Patent Gmbh | Wässrige pharmazeutische Zubereitung |
| US8597642B2 (en) * | 2007-07-19 | 2013-12-03 | Dsm Ip Assets B.V. | Tablettable formulations of lipophilic health ingredients |
| AU2008338015B2 (en) * | 2007-12-18 | 2013-03-07 | Merck Patent Gmbh | Process for preparing tetrahydroquinoline derivatives |
| WO2009087684A2 (en) * | 2008-01-04 | 2009-07-16 | Panjab University | Novel tetrahydroquinolines as aromatase inhibitors |
| WO2011009523A1 (en) | 2009-07-24 | 2011-01-27 | Merck Patent Gmbh | Eg5 as biomarker in rare thoracic cancer |
| EP2620438A1 (en) * | 2012-01-24 | 2013-07-31 | Laboratorios Del. Dr. Esteve, S.A. | Substituted pyrano and furanoquinolines, their preparation and use as medicaments |
| EP2647638A1 (en) * | 2012-04-02 | 2013-10-09 | Almirall, S.A. | Substituted tricyclic compounds with activity towards ep1 receptors |
| US9498540B2 (en) | 2013-03-15 | 2016-11-22 | Novartis Ag | Cell proliferation inhibitors and conjugates thereof |
| CN106029076B (zh) | 2013-11-18 | 2019-06-07 | 福马疗法公司 | 作为bet溴域抑制剂的苯并哌嗪组合物 |
| NZ720004A (en) | 2013-11-18 | 2020-03-27 | Forma Therapeutics Inc | Tetrahydroquinoline compositions as bet bromodomain inhibitors |
| WO2017214468A1 (en) | 2016-06-09 | 2017-12-14 | Tien Yang Der | Nanodroplet compositions for the efficient delivery of anti-cancer agents |
| CN110684031B (zh) * | 2019-08-14 | 2021-07-02 | 西北大学 | 一种反式-四氢呋喃/吡喃并四氢喹啉衍生手性化合物的不对称合成方法 |
| US20230312562A1 (en) * | 2020-07-02 | 2023-10-05 | Purdue Research Foundation | Tetrahydro-3h-pyrazolo quinolone and tetrahydro-3h-pyrrolo[3,2-f]quinoline -containing compounds and uses thereof |
| CA3201443A1 (en) | 2020-12-25 | 2022-06-30 | Toray Industries, Inc. | Tetrahydroquinoline derivative and medicinal use thereof |
| KR20250026152A (ko) | 2022-06-24 | 2025-02-25 | 도레이 카부시키가이샤 | 근위축성 측색경화증의 치료제 또는 예방제 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PT665897E (pt) * | 1992-10-01 | 2003-11-28 | Trustees Of Columbia U In The | Bibliotecas quimicas combinatorias complexas codificadas com etiquetas |
| CN1154640C (zh) * | 1993-10-01 | 2004-06-23 | 纽约市哥伦比亚大学理事 | 用标示物编码的多元组合化学库 |
| AU4972900A (en) | 1999-04-08 | 2000-11-14 | Arch Development Corporation | Use of anti-vegf antibody to enhance radiation in cancer therapy |
| WO2001027086A1 (en) * | 1999-10-14 | 2001-04-19 | Kaken Pharmaceutical Co., Ltd. | Tetrahydroquinoline derivatives |
| US20020165240A1 (en) * | 2001-03-29 | 2002-11-07 | Kimball Spencer David | Method of treating proliferative diseases using Eg5 inhibitors |
| US7250423B2 (en) | 2001-09-24 | 2007-07-31 | Chao-Jun Li | Methods for synthesizing heterocycles and therapeutic use of the heterocycles for cancers |
| DE10236910A1 (de) * | 2002-08-12 | 2004-03-11 | Grünenthal GmbH | Substituierte 1,2,3,4-Tetrahydrochinolinderivate |
-
2004
- 2004-12-14 EP EP08014660A patent/EP2033959B1/de not_active Expired - Lifetime
- 2004-12-14 SI SI200430985T patent/SI1761515T1/sl unknown
- 2004-12-14 ES ES04803833T patent/ES2315727T3/es not_active Expired - Lifetime
- 2004-12-14 BR BRPI0417838-6A patent/BRPI0417838A/pt not_active IP Right Cessation
- 2004-12-14 CA CA2550350A patent/CA2550350C/en not_active Expired - Fee Related
- 2004-12-14 AT AT04803833T patent/ATE413393T1/de active
- 2004-12-14 DK DK08014660.8T patent/DK2033959T3/da active
- 2004-12-14 DE DE502004012458T patent/DE502004012458D1/de not_active Expired - Lifetime
- 2004-12-14 PL PL08014660T patent/PL2033959T3/pl unknown
- 2004-12-14 AU AU2004309028A patent/AU2004309028B9/en not_active Ceased
- 2004-12-14 PT PT08014660T patent/PT2033959E/pt unknown
- 2004-12-14 JP JP2006544304A patent/JP5237555B2/ja not_active Expired - Fee Related
- 2004-12-14 EP EP04803833A patent/EP1761515B1/de not_active Expired - Lifetime
- 2004-12-14 PL PL04803833T patent/PL1761515T3/pl unknown
- 2004-12-14 DK DK04803833T patent/DK1761515T3/da active
- 2004-12-14 PT PT04803833T patent/PT1761515E/pt unknown
- 2004-12-14 AT AT08014660T patent/ATE507220T1/de active
- 2004-12-14 WO PCT/EP2004/014205 patent/WO2005063735A1/de not_active Ceased
- 2004-12-14 SI SI200431714T patent/SI2033959T1/sl unknown
- 2004-12-14 US US10/583,689 patent/US7868172B2/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| CA2550350A1 (en) | 2005-07-14 |
| DK2033959T3 (da) | 2011-07-25 |
| CA2550350C (en) | 2013-03-12 |
| SI2033959T1 (sl) | 2011-08-31 |
| ATE413393T1 (de) | 2008-11-15 |
| AU2004309028A1 (en) | 2005-07-14 |
| BRPI0417838A (pt) | 2007-04-17 |
| WO2005063735A1 (de) | 2005-07-14 |
| ATE507220T1 (de) | 2011-05-15 |
| PT2033959E (pt) | 2011-07-29 |
| AU2004309028B2 (en) | 2011-04-21 |
| EP2033959B1 (de) | 2011-04-27 |
| DE502004012458D1 (de) | 2011-06-09 |
| PL1761515T3 (pl) | 2009-04-30 |
| ES2315727T3 (es) | 2009-04-01 |
| PL2033959T3 (pl) | 2011-09-30 |
| DK1761515T3 (da) | 2009-02-16 |
| US20070203167A1 (en) | 2007-08-30 |
| EP2033959A1 (de) | 2009-03-11 |
| US7868172B2 (en) | 2011-01-11 |
| EP1761515B1 (de) | 2008-11-05 |
| PT1761515E (pt) | 2009-02-11 |
| JP5237555B2 (ja) | 2013-07-17 |
| EP1761515A1 (de) | 2007-03-14 |
| AU2004309028B9 (en) | 2011-06-16 |
| JP2007515419A (ja) | 2007-06-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PL1761515T3 (pl) | 2-(hetero-)arylo podstawione pochodne tetrahydrochinoliny | |
| AU2017382436B2 (en) | Compounds and methods for the targeted degradation of Rapidly Accelerated Fibrosarcoma polypeptides | |
| RU2217421C2 (ru) | Производные индола, обладающие антивирусной активностью | |
| NO20051870L (no) | 1H-1,2,4-triazol-3-karboksamidderivater som cannabinoid-CB1-reseptorligander | |
| AR035401A1 (es) | El uso de compuestos derivados de feniletenilo y feniletinilo; compuestos derivados de feniletinilo; compuestos derivados de feniletenilo; un procedimiento para la elaboracion de los mismos; y medicamentos que los contienen | |
| DK0958296T3 (da) | Heterocykliske forbindelser, fremgangsmåde til deres fremstilling og farmaceutiske præparater, der indeholder dem, og deres anvendelse i behandlingen af diabetes og beslægtede sygdomme | |
| NO20052534L (no) | Oksazolidinon- og/eller isokazolinderivater som antibakterielle stoffer | |
| KR920701167A (ko) | 약제학적 활성 화합물 | |
| HK33189A (en) | 1,2,3,9-tetrahydro-3-(imidazol-1-ylmethyl)-4h-carbazol-4-one derivatives | |
| AU1120599A (en) | New heterocyclic compounds and their use in medicine, process for their reparation and pharmaceutical compositions containing them | |
| CA2258949A1 (en) | Novel heterocyclic compounds process for their preparation and pharmaceutical compositions containing them and their use in the treatment of diabetes and related diseases | |
| CA2534798A1 (en) | Thiazole derivatives as cannabinoid receptor modulators | |
| HUT55228A (en) | Process for producing pharmaceutical composition comprising imidazole derivatives with antinociceptive effect | |
| MY125295A (en) | 1-arenesulfonyl-2-aryl-pyrrolidine and piperidine derivatives | |
| TR200102054T2 (tr) | Pirazolkarboksilik asit türevleri, hazırlanmaları ve bunları içeren farmasötik kompozisyonlar. | |
| ZA200500253B (en) | Ketones | |
| NO991384L (no) | Substituerte heterocykler som anti-tumormidler | |
| HUT77363A (hu) | 5-Lipoxigenáz inhibitor hatású azolszármazékok, eljárás előállításukra és a vegyületeket tartalmazó gyógyszerkészítmények | |
| ATE444965T1 (de) | Sich als therapeutische mittel eignende arylalkylindole mit affinität für den serotoninrezeptor, verfahren zu deren herstellung und pharmazeutische zusammensetzungen, die diese enthalten | |
| NO20060191L (no) | 1-(alkylaminoalkyl-pyrolidin-/piperidinyl)2,2-difenylacetamidderivater som muskarinreceptoragonister | |
| IL103021A0 (en) | Imidazoindolizine derivatives,their preparation and pharmaceutical compositions containing them | |
| PH12022553516A1 (en) | Novel pyrazole derivatives | |
| AU2003262931A1 (en) | Substituted 5-chroman-5-yl-ethylamine compounds and their use for the treatment of glaucoma | |
| PL1660484T3 (pl) | Metyloindole i metylopirolopirydyny jako agoniści receptora adrenergicznego α-1 | |
| ATE343580T1 (de) | Tetracyclische arylcarbonyl indole mit serotoninrezeptoraffinität als arzneimittel, verfahren zu ihrer herstellung und pharmazeutische zubereitungen |